NCT06726525

Hydroxypropyl-methylcellulose and GlicoPro® Eyedrops in the Treatment of Dry Eye Disease: Clinical Study

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 44 (actual)
• Sponsor: University of Milan · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The goal of this clinical trial is to learn if Hydroxypropyl-methylcellulose and GlicoPro® eyedrops work to treat mild-to-moderate dry eye disease in adult patients. The main questions it aims to answer are: Do Hydroxypropyl-methylcellulose and GlicoPro® eyedrops reduce patients' symptoms? Do Hydroxypropyl-methylcellulose and GlicoPro® eyedrops increase patients' tear film stability? Researchers will compare Hydroxypropyl-methylcellulose and GlicoPro® eyedrops to Hydroxypropyl-methylcellulose without GlicoPro® eyedrops to see if Hydroxypropyl-methylcellulose and GlicoPro® formulation works better to treat dry eye.. Participants will * Take Hydroxypropyl-methylcellulose and GlicoPro® eyedrops or Hydroxypropyl-methylcellulose eyedrops every day for 3 months * Visit the clinic 3 times in 3 months for checkups and tests

Conditions

• Dry Eye

Interventions

Type	Name	Description
DEVICE	HPMC+GlicoPro eyedrops	HPMC+GlicoPro eyedrops, artificial tears for dry eye disease
DEVICE	Hydroxypropyl-methylcellulose	Hydroxypropyl-methylcellulose eyedrops, artificial tears for dry eye disease

Timeline

• Start date: 2024-02-03
• Primary completion: 2024-09-12
• Completion: 2024-09-12
• First posted: 2024-12-10
• Last updated: 2024-12-10

Locations

1 site across 1 country: Italy